[ad_1]
With some countries starting the vaccination phase with the viral vaccine against the emerging coronavirus, the victim is waiting to know the initial results of the vaccination coin.
In reference to the effectiveness of the emerging anti-coronavirus vaccine developed by the American company “Pfizer” and the German company “Biontech”, the US Food and Drug Administration announced this Tuesday that the effect of the new product appears to starting with the first dose.
The aforementioned vaccine is administered in two doses, 3 weeks apart, but according to the US agency, “it appears to provide protection against the virus after the first dose.”
The US announcement is consistent with that presented by previous studies on the vaccine, which found evidence of “partial protection against the disease 12 days after the first dose”, despite the need for two doses to obtain the full benefit of the same .
To coincide with the start of distribution of the vaccine in Britain on Tuesday, Professor Sir Munir Bir Muhammad said that people who receive two doses of the vaccine “will become completely immune 7 days after the second dose.”
Studies have shown that the “Pfizer” and “Biontech” vaccine are 95% effective and work for all age groups.
The US Food and Drug Administration added that “the Pfizer Corona vaccine is consistent with our recommendations,” in an apparent indication of the imminent issuance of a permit for its distribution in the United States.
The authority advised people who had previously had a crown to receive the vaccine, as “they can become infected again and the vaccine can also be beneficial for them.”
But the US newspaper “Washington Post” reported on Tuesday that “Pfizer” had informed US officials that it could not obtain large quantities of the vaccine it was developing with “Biontech” until next summer.
The newspaper added, citing sources familiar with the matter, that “this impossibility is due to the fact that other countries rushed to buy most of the quantities produced by the company or those it intends to produce in the coming months.”
He said the provision of massive additional quantities of the vaccine could be possible in late June or July 2021.